Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TXG · against 1,216 other Healthcare companies
Ranked #762 of 1,217 · scores higher than 37% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 30–39, including TXG · Click a bar to see the companies
Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | TXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -4.3% | 6.1% | 22% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 2.8% | 5.8% | 37% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 762 | 10.8B USD | 37 | 41 | |
| 762 | 1.0B EUR (≈$1.1B) | 37 | 16 | |
| 762 | 3.0B SEK (≈$301M) | 37 | 56 | |
| 762 | 771M EUR (≈$848M) | 37 | 53 | |
| 762 | 8.5B USD | 37 | 28 | |
| 774 | 10.2B CNY (≈$1.4B) | 36 | 69 | |
| 774 | 105.7B KRW (≈$76M) | 36 | 37 | |
| 774 | 72.6B JPY (≈$494M) | 36 | 58 | |
| 774 | 16.5B CNY (≈$2.3B) | 36 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score